Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | TSPO | P30536 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18810600 | 0.88 | L3MBTL1 (0.47) | L3MBTL1KDM4EATMKMT2AIL1R1 | |
| SCHEMBL18810651 | 0.86 | KDM4E (0.42) | L3MBTL1KDM4EATMKMT2AIL1R1 | |
| SCHEMBL21035263 | 0.85 | KDM4E (0.38) | L3MBTL1KDM4EATMKMT2AIL1R1 | |
| SCHEMBL18810597 | 0.85 | L3MBTL1 (0.45) | L3MBTL1KDM4EATMKMT2AIL1R1 | |
| SCHEMBL18810609 | 0.85 | L3MBTL1 (0.50) | L3MBTL1KDM4EATMKMT2AIL1R1 | |
| SCHEMBL20311767 | 0.85 | L3MBTL1 (0.35) | L3MBTL1KDM4EATMKMT2AIL1R1 | |
| SCHEMBL21035265 | 0.84 | L3MBTL1 (0.48) | L3MBTL1KDM4EATMKMT2AIL1R1 | |
| SCHEMBL18419116 | 0.84 | L3MBTL1 (0.39) | L3MBTL1KDM4EATMKMT2AIL1R1 | |
| SCHEMBL20311770 | 0.83 | L3MBTL1 (0.35) | L3MBTL1KDM4EATMKMT2AIL1R1 | |
| SCHEMBL21036045 | 0.83 | L3MBTL1 (0.42) | L3MBTL1KDM4EATMKMT2AIL1R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190165279-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | JNC CORPORATION (JP) | 2019-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190165279-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | TCF4, LGR4, OR51E2 | L3MBTL1 834/4885KDM4E 396/4885ATM 1673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.